NEW YORK (GenomeWeb News) — An Ontario Superior Court of Justice has cleared the way for Luminex to acquire Tm Bioscience, Tm said yesterday.
 
Tm last week said that the deal could close within a day of the court’s favorable decision.
 
As GenomeWeb News reported in December, the deal would exchange one Tm share for every .06 share of Luminex. Luminex said at the time that would be roughly a 41.5 percent premium for Tm’s shareholders.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.